This study aimed to test whether scored biologic functions can predict individual life expectancies and to investigate the disease-related and time-related differences in evaluated associations. A biologic score was defi ned as the fi rst principal component score of the fi ve physiological tests. Study participants were 4,871 people aged 35 -74 years at baseline examination in 1970 -1972 and followed until the end of 1999. We evaluated the prognostic value of the biologic score by Cox proportional hazard analysis. In all age and sex groups, increasing trends of mortality for all diseases by increment of biologic score were observed after adjustment for potential risk factors. The validity of the biologic score was significant throughout the entire study period. Each disease except cancer showed a signifi cant association with biologic score at baseline examination. In conclusion, the biologic score is a valid predictor of life span in this large-scale prospective study of middle-aged and elderly Japanese.
A GING is characterized by deterioration of biologic functions, resulting in increased morbidity and mortality. Although the effect of aging differs among organs, much effort has been devoted to develop a comprehensive biologic marker in human and animal studies that can be used to assess the global biologic function refl ecting the aging process ( 1 -7 ) . Although various regression techniques have been used to calculate a comprehensive biologic marker representing biologic age ( 4 , 8 , 9 ) , various problems such as the regression to sample mean age, that biologic age values calculated for persons younger than sample mean age tend to be too old and those for persons older than sample mean age, too young, have been described ( 10 ) . Other techniques were also used to establish a comprehensive biologic marker ( 6 , 10 ) . Nakamura and colleagues ( 11 ) applied principal component analysis for the assessment of a comprehensive biologic marker and proved the marker ' s validity. To evaluate the reliability and validity of candidate biologic markers of aging, the relationship between the biologic markers and consequent morbidity and mortality should be demonstrated. Relatively high biologic age has been observed in hypertensive patients ( 4 ), whereas low biologic age has been observed in people who survive or lead active daily lives ( 6 , 8 , 12 , 13 ) . However, such studies are limited, follow-up periods are relatively short, or results are controversial ( 14 ) .
A battery of age-related physiological functions devised by Hollingsworth and Jablon ( 9 ) were measured in participants of the Adult Health Study (AHS) cohort of the Atomic Bomb Casualty Commission (ABCC), during 1970 -1972 ( 15 , 16 ) . Five physiological tests, including handgrip strength, auditory acuity, vibration perception, skin elasticity, and reaction time, were administered in all AHS participants and the results correlated signifi cantly with age ( 9 ) . Using those fi ve physiological tests, the " biologic score " was devised as " global biologic function " based on the fi rst principal component identifi ed by principal component analysis. Since then, the ABCC and its successor, the Radiation Effects Research Foundation (RERF), have been conducting a mortality survey. Using this data set, we investigated the association between biologic score and mortality for 30 years and evaluated the cause-related difference and time-related difference in the association.
Materials and Methods

Participants
The participants are members of the AHS cohort of the RERF. The AHS began in 1958 as a clinical cohort study to investigate the long-term medical effects of exposure to atomic bomb radiation among the survivors and unexposed controls in Hiroshima and Nagasaki. Approximately 20,000 persons were invited to participate in the biennial health examination program. A detailed description of the examinations, which included clinical evaluations and routine laboratory tests, is available elsewhere ( 17 ) .
Physiological Tests
Current study participants were derived from 6,129 persons of the AHS cohort who underwent a battery of noninvasive age-related physiological tests between July 1970 and June 1972 in Hiroshima. Physiological tests conducted for all participants included handgrip strength, auditory acuity, vibration perception, skin elasticity, and reaction time.
Handgrip strength (in kilograms) was measured twice for both the left and right hands with the participant in a standing position using a dynamometer. Grip devices were calibrated with known weights. The maximum grip strength among all measurements was used for the present analysis. Auditory acuity (in decibels) was measured for each ear at 4,000 cycles/s. Vibration perception was measured as the minimal voltage intensity required for perception of a stimulus from an electric vibrometer applied at the ankle. Skin elasticity was measured as time (seconds) required for the skin to fl atten to a normal level after a standard pinch on the back of the hand. Reaction time for a complex task was measured by the light extinction test. The task was to switch off randomly placed fl ashing lights, with each switch off activating the next light. Analysis was restricted to 4,871 participants (1,676 men and 3,195 women) who lived in Hiroshima, who were 35 -74 years old at the time of examination, and who completed all fi ve measurements in addition to providing other clinical information.
Biologic Score
Principal component analysis was applied to estimate the biologic score of each individual. In the analysis, each of the fi ve physiological test measurements was initially standardized by dividing the value by its standard deviation, after log transformation of both skin elasticity and reaction time. Table 1 lists the coeffi cients of the fi rst principal component and the second component, and the proportion of variance. The fi rst principal component accounts for 53.3% of the total variation in the fi ve measurements. Although the second principal component contained some information about the total variation, we defi ned the fi rst component score as the biologic score for each individual. Because all coeffi cients for the fi rst component are almost equal, the component could be interpreted as global biologic function.
Other Measurements
Clinical examinations included medical history, general physical examinations, height and body weight measurements, serum cholesterol concentration measurements, and self-administrated questionnaires. Body mass index (BMI) was calculated as body weight (kilograms) divided by the square of the height (meter). Blood pressure was measured by a sphygmomanometer at the right arm with the participant in the seated position. Information about smoking habits and alcohol intake was obtained from self-administrated questionnaires conducted during 1965 -1968. Categories for smoking habits were " never, " " former, " and " current. " For current smokers, a question was included about the number of cigarettes smoked. Categories for alcohol intake were " never " and " former/current. " Individual radiation dose estimates were based on RERF ' s 2002 Dosimetry System.
Mortality Follow-Up
Mortality was followed up for the entire study sample from the time of physiological tests and examinations in 1970 -1972 until the end of 1999. Deaths were routinely identifi ed through Japan ' s Koseki (obligatory household registries) system, and ascertainment was essentially complete. Underlying causes of death were obtained from death certifi cates and classifi ed as cancer (140 -208 by International Classifi cation of Diseases [ICD] 8th or 9th), heart disease (390 -429 by ICD 8th or 9th), coronary heart disease (CHD; 410 by ICD 8th or 9th), stroke (430 -438 by ICD 8th or 9th), cerebral infarction (433 and 434 by ICD 8th or 9th), cerebral hemorrhage (431 by 8th or 9th), and pneumonia (480 -487 by ICD 8th or 9th). Pneumonia was chosen because it is one of the major causes of death in the elderly population in Japan.
Statistical Analysis
Relative risk (RR) of mortality associated with biologic score was adjusted multivariately for potentially confounding factors applying Cox proportional hazard analysis, in both men and women. The factors considered in the model were age at baseline, systolic blood pressure, BMI, smoking and drinking habits, serum cholesterol level, and radiation dose. Allowance for the effect of radiation dose was necessary because the study population included atomic bomb survivors exposed to radiation. When the RR of all causes of mortality, with the exception of externally caused deaths, was estimated according to the sex -age-specifi c quintile of biologic score, the third quintile was established as a reference. For the trend test, the mean value of the biologic score in each quintile category was assigned to the category. In the case of cause-specifi c mortalities, RR was calculated for each 1-score increment of biologic score. Analysis was carried out separately by sex. Deaths within the fi rst 2 years after the baseline were excluded from analysis. Secular trends of multivariate-adjusted RR for all causes of death, except external causes, were calculated by dividing the follow-up period from baseline examination (within 5 years, after 5 years, after 10 years, after 15 years, and after 20 years).
Results
The average age at baseline examination was 55.6 years for men and 53.9 years for women. The characteristics of the study participants by sex and age category are shown in Table 2 . The biologic score ranged from -3.4 to 4.5 for men and -3.4 to 5.0 for women. Figure 1 shows plots of biologic score according to age at examination for both sexes. A gradual increase in biologic score with age is apparent for both sexes.
Over the 27-year follow-up period, 2,475 deaths were registered, in addition to those due to external causes, which included trauma and suicide. Table 3 lists the numbers of cause-specifi c deaths for both men and women. The crude mortality was 23.3 per 1,000 person-years. Figure 2 shows the crude mortality rates according to biologic score by sex and age category. In general, higher mortality rates were noted among participants with higher biologic scores at baseline, even in the same chronological age category in both sexes.
Multivariate-adjusted RR was compared among different biologic score categories divided into quintiles for each age and sex group, using the third quintile group as reference ( Figure 3 ) . In all age and sex groups, increasing trends of mortality by increment of biologic score were observed.
Multivariate-adjusted RR of all causes of death, with the exception of external causes, for each 1-score increment of biologic score in men was signifi cantly high (RR 1.22, 95% confi dence interval [95% CI], 1.14 -1.31). Multivariateadjusted RRs for heart disease, CHD, stroke, and pneumonia were signifi cant and did not differ from the age-adjusted RR values ( Table 4 ) . Multivariate-adjusted RR of all causes of death, with the exception of external causes, for each 1-score increment of biologic score in women was signifi cantly high (RR 1.27, 95% CI, 1.20 -1.35). All multivariate-adjusted RRs except for cancer were signifi cant, which were almost similar to the age-adjusted RR values ( Table 4 ) .
Secular trends of multivariate-adjusted RR of all causes of death except for external causes showed signifi cantly higher mortality risks with higher biologic score in any follow-up period. Similar RR levels were observed after 5 years. Those observations were noted in both sexes ( Table 5 ) .
Discussion
The present analysis identifi ed a signifi cant relationship between biologic score based on fi ve physiological tests performed in 1970 -1972 and a subsequent 30-year mortality. The trend was observed in both sexes in each chronological age category, even after adjusting for covariates related to mortality. The advantages of the present study are its large number of participants including men and women with a wide range of age at the time of baseline examination and a long follow-up period. The confi rmation of death in this cohort allowed us to evaluate the value of a " comprehensive biologic marker " in predicting life span, although death certifi cate accuracy for several disease categories in the study period was not fully examined.
There are a few longitudinal studies related to biologic age and clinical condition or mortality. In an aging study of 1,086 men aged 17 -102 years, Borkan and colleagues ( 6 ) found that the individuals of the deceased group were biologically older than the survivors at the time of fi rst examination. However, the Normative Aging Study reported by Costa ( 5 ) did not fi nd a good correlation between biologic age (calculated with a weighted regression equation) and signs of aging over the course of 5 years. Uttley and colleagues ( 13 ) retrospectively analyzed the relationship between biologic age based on 38 variables and mortality 10 years later and reported that, in general, the participants who died had been estimated as older than the participants who had survived. Such studies did not cover a wide chronological age range for both sexes and the follow-up periods were relatively short. In addition, our analysis was performed by excluding deaths during the fi rst 2 years of the follow-up period to avoid comorbidity.
In the Midwest Mennonite Study, functional -biologic age based on regression analysis did not accurately predict 10-year survival, although the independent variables were associated with mortality ( 13 ) . In contrast, the relationship between biologic score and mortality was signifi cant for all age categories for both sexes in our study based on principal component analysis. Grip strength, which is one component of the biologic score in this study, was an accurate and consistent predictor of mortality among the same cohort ( 18 ) . The methodological differences between the Midwest Mennonite Study and our study might have contributed to the different statistical signifi cances of the results ( 10 ). We evaluated the RRs for specifi c causes of death, including cancer, heart disease, stroke, and pneumonia. It is interesting that the biologic score was strongly associated with cardiovascular disease (CVD) mortality and pneumonia mortality, but not cancer. The RRs for stroke and CHDs were almost similar. Those fi ndings suggest that CVD and cancer relate differently to the aging phenomenon. A close relationship between the aging process and CVD, especially ischemic heart disease, has been observed in previous studies ( 19 , 20 ) . Studies at the cellular level also showed that vascular disorders increase linearly with age ( 21 ) . Agerelated changes in vascular reactivity, which refl ect cellular changes in, for example, endothelial cells, smooth muscle cells, platelets, and macrophages, as well as in environmental factors such as increasing hypertension and hyperlipidemia, relate to vascular disorders as well ( 22 , 23 ) . Because these changes occur progressively in more or less every person, the development of atherosclerotic diseases is an important manifestation of the aging phenomenon in human beings. Although the biologic score in our study was not necessarily based on measurements related to the cardiovascular system, a strong relationship was observed with death from atherosclerotic disease. This may confi rm the usefulness of biologic score as an aging marker, and the marker may predict aging-related disorders of the cardiovascular system.
One of the criticisms concerning the use of an aging marker is that if it includes risk factors such as blood pressure and body weight, it may be too strongly associated with CVDs ( 5 ). The present score avoids that association because it does not use those risk factors in the equation. Bulpitt ( 24 ) pointed out that aging occurs at different rates in various organs, making it diffi cult to represent systemic aging as one index, suggesting that the use of measurements that include as many systems as possible is necessary for a comprehensive assessment of aging. From a clinical point of view, however, an aging marker based on a small number of simple noninvasive tests is likely to be of a more practical value. Biologic score as determined in the present study, and its dependence on only fi ve variables, could predict mortality.
There was no signifi cant difference in cancer mortality by biologic score within the same chronological group, and this result was not affected by covariates such as smoking habits and radiation exposure. This suggests that cancer is more weakly related than CVD to age-related changes in biologic function. We found no other report, longitudinal or cross-sectional, on the relationship between an aging marker and cancer. Whether development of cancer results from aging is still controversial. One hypothesis is that the incidence of cancer is higher among the elderly population simply because they have been exposed to carcinogens for a longer time and that aging itself does not promote carcinogenesis ( 25 , 26 ) . But recent knowledge as to the mechanisms including DNA repair and telomere biology resulted in reevaluation of links between aging and cancer ( 27 -29 ) . Because aging is complex, investigation of relationship Note : CH = cerebral hemorrhage; CHD = coronary heart disease; CI = cerebral infarction. between aging markers other than biologic functions and cancer is required.
The observation periods of other studies were all shorter than 10 years ( 6 , 13 ). The 30-year follow-up in our study allowed analysis of the time-dependent signifi cance of biologic score by permitting us to divide the time into shorter periods. Review by time periods showed that a signifi cant association was observed 2 -30 years after initiation of the study. The RR at 5 years or less since baseline was highest. However, the RRs at any follow-up period more than 5 years since baseline were similar. This suggests that the score at one point in time predicted mortality 30 years later.
An attempt to formulate aging markers using physiological functions using an ABCC study population, consisting primarily of atomic bomb survivors and their controls, was started in the 1960s to test the hypothesis that ionizing radiation promotes aging ( 30 , 31 ) . The results, however, did not reveal any association between radiation and such aging markers ( 16 ) , in keeping with the theory of Strehler and colleagues that aging is a more complex phenomenon than radiation-related life shortening ( 32 ) . In the present study population as well, biologic score did not correlate with the radiation dose. Furthermore, the association between biologic score and mortality was independent of the radiation dose. Hence, we think that the results of the present study can be extrapolated to the general population. Note : RR was adjusted for age, systolic blood pressure, body mass index, total cholesterol, smoking habits, alcohol consumption, and radiation dose. CH = cerebral hemorrhage; CHD = coronary heart disease; CI = cerebral infarction. Note: RR was estimated for each 1-score increment of biologic score. CI = confi dence interval.
